Annual Current Ratio
5.52
+0.91+19.74%
31 December 2023
Summary:
Y-mAbs Therapeutics annual current ratio is currently 5.52, with the most recent change of +0.91 (+19.74%) on 31 December 2023. During the last 3 years, it has fallen by -0.74 (-11.82%). YMAB annual current ratio is now -66.77% below its all-time high of 16.61, reached on 31 December 2018.YMAB Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Ratio
3.92
+1.00+34.25%
30 September 2024
Summary:
Y-mAbs Therapeutics quarterly current ratio is currently 3.92, with the most recent change of +1.00 (+34.25%) on 30 September 2024. Over the past year, it has dropped by -1.35 (-25.62%). YMAB quarterly current ratio is now -78.00% below its all-time high of 17.82, reached on 30 September 2018.YMAB Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
YMAB Current Ratio Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +19.7% | -25.6% |
| 3 y3 years | -11.8% | -56.9% |
| 5 y5 years | -66.8% | -44.9% |
YMAB Current Ratio High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -24.0% | +19.7% | -56.9% | +34.3% |
| 5 y | 5 years | -66.8% | +19.7% | -74.9% | +34.3% |
| alltime | all time | -66.8% | +19.7% | -78.0% | +34.3% |
Y-mAbs Therapeutics Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 3.92(+34.2%) |
| June 2024 | - | 2.92(-52.5%) |
| Mar 2024 | - | 6.15(+11.4%) |
| Dec 2023 | 5.52(+19.7%) | 5.52(+4.7%) |
| Sept 2023 | - | 5.27(+10.3%) |
| June 2023 | - | 4.78(0.0%) |
| Mar 2023 | - | 4.78(+3.7%) |
| Dec 2022 | 4.61(-36.5%) | 4.61(+10.8%) |
| Sept 2022 | - | 4.16(-20.5%) |
| June 2022 | - | 5.23(-14.5%) |
| Mar 2022 | - | 6.12(-15.7%) |
| Dec 2021 | 7.26 | 7.26(-20.1%) |
| Sept 2021 | - | 9.09(-23.5%) |
| June 2021 | - | 11.88(-23.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | 15.53(+148.1%) |
| Dec 2020 | 6.26(-59.9%) | 6.26(-7.1%) |
| Sept 2020 | - | 6.74(-35.2%) |
| June 2020 | - | 10.40(-18.7%) |
| Mar 2020 | - | 12.79(-18.0%) |
| Dec 2019 | 15.60(-6.1%) | 15.60(+119.1%) |
| Sept 2019 | - | 7.12(-21.2%) |
| June 2019 | - | 9.04(-32.0%) |
| Mar 2019 | - | 13.30(-19.9%) |
| Dec 2018 | 16.61(+44.1%) | 16.61(-6.8%) |
| Sept 2018 | - | 17.82(+42.3%) |
| June 2018 | - | 12.52(+8.6%) |
| Dec 2017 | 11.53(+98.8%) | 11.53 |
| Dec 2016 | 5.80 | - |
FAQ
- What is Y-mAbs Therapeutics annual current ratio?
- What is the all time high annual current ratio for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics annual current ratio year-on-year change?
- What is Y-mAbs Therapeutics quarterly current ratio?
- What is the all time high quarterly current ratio for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics quarterly current ratio year-on-year change?
What is Y-mAbs Therapeutics annual current ratio?
The current annual current ratio of YMAB is 5.52
What is the all time high annual current ratio for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high annual current ratio is 16.61
What is Y-mAbs Therapeutics annual current ratio year-on-year change?
Over the past year, YMAB annual current ratio has changed by +0.91 (+19.74%)
What is Y-mAbs Therapeutics quarterly current ratio?
The current quarterly current ratio of YMAB is 3.92
What is the all time high quarterly current ratio for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high quarterly current ratio is 17.82
What is Y-mAbs Therapeutics quarterly current ratio year-on-year change?
Over the past year, YMAB quarterly current ratio has changed by -1.35 (-25.62%)